Accès ouvert
2025
article
OpenAlex
Camille N. Kotton, Deepali Kumar, Sunwen Chou, Randall T. Hayden et autres
Abstract visual presentation is available at https://journals.lww.com/transplantjournal/fulltext/2025/07000/the_fourth_international_consensus_guidelines_on.6.aspx
us, ca, ch, no, br
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Fien Horsten, Sunwen Chou, Sarah Gillemot, Yves Debaveye et autres
BACKGROUND: Cytomegalovirus (CMV) infection poses a significant risk to immunosuppressed transplant recipients, manifesting through primary infection, reinfection, or reactivation. METHODS: We analyzed the emergence of drug resistance in CMV infection in 3 patients who were later found to have received an allograft …
be, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Per Ljungman, Roy F. Chemaly, Fareed Khawaya, Sophie Alain et autres
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of CMV infection and disease were developed and most recently published in 2017. …
se, us, ch, es, gb
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sunwen Chou
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sunwen Chou, J Watanabe
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Nicholas Streck, Mark J. Espy, Matthew J. Ferber, Eric W. Klee et autres
ABSTRACT Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence of CMV disease in this patient population; however, there is concern about increasing antiviral resistance. …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sunwen Chou, Sophie Alain, Carlos Cervera, Roy F. Chemaly et autres
BACKGROUND: This drug resistance analysis of a randomized trial includes 234 patients receiving maribavir and 116 receiving investigator-assigned standard therapy (IAT), where 56% and 24%, respectively, cleared cytomegalovirus DNA at week 8 (treatment responders). METHODS: Baseline and posttreatment plasma samples were tested …
us, fr, ca, dk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Martin Schütz, Regina Müller, Eileen Socher, Christina Wangen et autres
The complex host interaction network of human cytomegalovirus (HCMV) involves the regulatory protein kinase pUL97, which represents a viral cyclin-dependent kinase (CDK) ortholog. pUL97 interacts with the three human cyclin types T1, H, and B1, whereby the binding region of cyclin T1 …
de, au, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sunwen Chou, Steven B. Kleiboeker
us, de
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Martin Schütz, Regina Müller, Eileen Socher, Christina Wangen et autres
Abstract The complex network of host interaction of the human cytomegalovirus (HCMV) involves the regulatory protein kinase pUL97, which represents a viral cyclin-dependent kinase (CDK) ortholog. pUL97 interacts with the three human cyclin types T1, H and B1, whereby the binding region …
de, au, us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Sunwen Chou
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Sunwen Chou, Matthew Watters, Rohita Sinha, Steven B. Kleiboeker
us
(code pays fourni par la source)